Left Ventricular Late Gadolinium Enhancement for Arrhythmic Risk Prediction in ARVC
Circulation: Arrhythmia and Electrophysiology · 2026
DOI: 10.1161/circep.125.014265 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Circulation: Arrhythmia and Electrophysiology, 2026. Verfasst von Corrado De Marco und 34 weiteren Autor:innen. Beteiligte Einrichtung: Cardiovascular Genetics Center and Electrophysiology Service, Montreal Heart Institute, Department of Medicine, Université de Montréal, QC, Canada (C…. Hauptthemen laut MEDLINE: Arrhythmogenic Right Ventricular Dysplasia, Contrast Media, Heart Ventricles, Magnetic Resonance Imaging, Cine. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 51 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: The arrhythmogenic right ventricular cardiomyopathy (ARVC) risk calculator estimates the risk of incident sustained ventricular arrhythmia (VA) and performs well in ARVC populations meeting 2010 Task Force Criteria. However, the calculator includes no measure of left ventricular (LV) structure and function, while late gadolinium enhancement (LGE) on cardiac magnetic resonance shows promise in arrhythmic risk prediction. This study aims to evaluate whether LV LGE on cardiac magnetic resonance can further refine ARVC VA risk stratification. METHODS: Patients with definite ARVC, no prior sustained VA, and contrast-enhanced cardiac magnetic resonance at baseline were followed at 17 centers. Survival analyses were performed to assess LV LGE effect on VA prediction, and its incremental prognostic value on the risk calculator was evaluated using Cox proportional hazard models. The presence of high-risk LGE, defined as LV epicardial, transmural, or combined septal and free-wall LGE, was studied as a sensitivity analysis. RESULTS: Of 385 patients (39.6±15.4 years, 39.7% male, 54.0% probands), 132 (34.3%) had LV LGE on cardiac magnetic resonance, with 98 (25.5%) having a high-risk pattern. Over 3.1 [1.2–5.8] years of follow-up, 67 (17.4%) patients experienced VA. In univariable analysis, both LV LGE (hazard ratio, 1.82; P =0.014) and high-risk LV LGE (hazard ratio, 1.85; P =0.017) were associated with higher risk for VA. However, after adjusting for the ARVC calculator–estimated risk, the presence of neither LV LGE ( P =0.85) nor high-risk LV LGE ( P =0.87) independently predicted sustained VA. (graphic abstract) CONCLUSIONS: While associated with the risk of VA in ARVC, LV LGE did not provide incremental prognostic value for incident VA risk prediction compared with the ARVC risk calculator.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cardiovascular Genetics Center and Electrophysiology Service, Montreal Heart Institute, Department of Medicine, Université de Montréal, QC, Canada (C.D.M., R.T., L.-P.D., J.C.-T.).
- Division of Cardiology, Department of Medicine (B.A., A.G., H.C., C.A.J.), Johns Hopkins University School of Medicine, Baltimore, MD.
- Division of Heart and Lungs, Department of Cardiology (A.S.J.M.t.R.), University Medical Center Utrecht, Utrecht University, the Netherlands.
- European Reference Network for Rare, Low Prevalence, and Complex Diseases of the Heart: ERN GUARD-Heart (A.S.J.M.t.R., H.K.J., E.A., C.C., D.S., M.M., J.P.v.T., B.K.V., L.P.B.).
- Arrhythmia Unit, Department of Cardiology, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain (A.D.M.).
- BioHeartCardiovascular Diseases Research Group, Bellvitge Biomedical Research Institute, Barcelona, Spain (A.D.M.).
ORCID-Profile: Corrado De Marco, Babken Asatryan, Anneline S J M Te Riele, Andrea Di Marco, Alessio Gasperetti, Antoine Delinière, Jason D Roberts, Henrik K Jensen, Brianna Davies, Andrew D Krahn, Rafik Tadros, Anneli Svensson, Silvia Castelletti, Lia Crotti, Pyotr G Platonov, Karolina Borowiec, Elżbieta K Biernacka, Elena Arbelo, Louis-Philippe David, Ardan M Saguner, Jeff S Healey, Chiara Cappelletto, Davide Stolfo, Marco Merlo, Kristina H Haugaa, Firat Duru, J Peter van Tintelen, Birgitta K Velthuis, Hugh Calkins, Stefan L Zimmerman, Cynthia A James, Julia Cadrin-Tourigny
Zitieren
APA
De Marco, C., Asatryan, B., Te Riele, A. S. J. M., Di Marco, A., Gasperetti, A., Delinière, A., Roberts, J. D., Jensen, H. K., Davies, B., Krahn, A. D., Tadros, R., Svensson, A., Castelletti, S., Crotti, L., Platonov, P. G., Borowiec, K., Biernacka, E. K., Arbelo, E., David, L. P., …, & Cadrin-Tourigny, J. (2026). Left Ventricular Late Gadolinium Enhancement for Arrhythmic Risk Prediction in ARVC. Circulation: Arrhythmia and Electrophysiology. https://doi.org/10.1161/circep.125.014265
Vancouver
De Marco C, Asatryan B, Te Riele ASJM, Di Marco A, Gasperetti A, Delinière A, et al. Left Ventricular Late Gadolinium Enhancement for Arrhythmic Risk Prediction in ARVC. Circulation: Arrhythmia and Electrophysiology. 2026. doi:10.1161/circep.125.014265
BibTeX
@article{DeMarco2026,
author = {De Marco, Corrado and Asatryan, Babken and Te Riele, Anneline S J M and Di Marco, Andrea and Gasperetti, Alessio and Delinière, Antoine and Roberts, Jason D and Jensen, Henrik K and Davies, Brianna and Krahn, Andrew D and Tadros, Rafik and Svensson, Anneli and Castelletti, Silvia and Crotti, Lia and Platonov, Pyotr G and Borowiec, Karolina and Biernacka, Elżbieta K and Arbelo, Elena and David, Louis-Philippe and Saguner, Ardan M and Healey, Jeff S and Brunckhorst, Corinna and Cappelletto, Chiara and Stolfo, Davide and Merlo, Marco and Rootwelt-Norberg, Christine and Haugaa, Kristina H and Duru, Firat and van Tintelen, J Peter and Velthuis, Birgitta K and Calkins, Hugh and Zimmerman, Stefan L and James, Cynthia A and Bosman, Laurens P and Cadrin-Tourigny, Julia},
title = {Left Ventricular Late Gadolinium Enhancement for Arrhythmic Risk Prediction in ARVC},
journal = {Circulation: Arrhythmia and Electrophysiology},
year = {2026},
doi = {10.1161/circep.125.014265}
}
EUVIMED